Evidence map›Paper›PMID 28930284›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men.

Franziska Plessow, Dean A Marengi, Sylvia K Perry, Julia M Felicione, Rachel Franklin, Tara M Holmes, Laura M Holsen, Nikolaos Makris, Thilo Deckersbach, Elizabeth A Lawson

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06945926 (The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery:Two-Stage Designs for Phase II Clinical Trials), which is not on this map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06945926 phase2completednot on this mapstarted 2025, after this paper: background citation

The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery:Two-Stage Designs for Phase II Clinical Trials

TypeinterventionalSponsorZhejiang UniversityRan2025 to 2026Enrolled227ConditionsCervical Spinal Stenosis, Thoracic Spinal Stenosis, Lumbar Spinal Stenosis, Rotator Cuff InjuryArmsoxytocin nasal spray
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Franziska PlessowNeuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Dean A MarengiNeuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Sylvia K PerryNeuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Julia M FelicioneDivision of Neurotherapeutics, Massachusetts General Hospital, Charlestown, MA, USA.
Rachel FranklinDivision of Neurotherapeutics, Massachusetts General Hospital, Charlestown, MA, USA.
Tara M HolmesClinical Research Center, Massachusetts General Hospital, Boston, MA, USA.
Laura M HolsenDivision of Women's Health, Department of Medicine and Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.
Nikolaos MakrisDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA.
Thilo DeckersbachDivision of Neurotherapeutics, Massachusetts General Hospital, Charlestown, MA, USA.
Elizabeth A LawsonNeuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Massachusetts General Hospital · USHarvard University · USBrigham and Women's Hospital · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Hormones/Genes in Women's Health: From Bench to BedsideK12HD051959 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLDSTEIN, JILL M, REXRODE, KATHRYN M · 2005 to 2023
$8.8M
Ghrelin Modulation of Mesolimbic Reward Signaling in Stress-induced HyperphagiaR01DK104772 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI HOLSEN, LAURA MCGRATH · 2016 to 2020
$2.7M
NCATS NIH HHS UL1 TR001102NICHD NIH HHS K12 HD051959NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK104772
6 · The paper itself

Abstract

Recent research indicates that the hypothalamic neuropeptide hormone oxytocin is a key central nervous system factor in the regulation of food intake and weight. However, the mechanisms underlying the anorexigenic effects of oxytocin in humans are unknown and critical to study to consider oxytocin as a neurohormonal weight loss treatment. We performed a randomized, double-blind, placebo-controlled crossover study with single-dose intranasal oxytocin (24 IU) in ten overweight or obese, otherwise healthy men. Following oxytocin/placebo administration, participants completed an established functional magnetic resonance imaging food motivation paradigm. We hypothesized that oxytocin would reduce the blood oxygenation level-dependent (BOLD) signal to high-calorie food vs non-food visual stimuli in the ventral tegmental area (VTA), the origin of the mesolimbic dopaminergic reward system. Following oxytocin administration, compared to placebo, participants showed bilateral VTA hypoactivation to high-calorie food stimuli. A secondary exploratory whole-brain analysis revealed hypoactivation in additional hedonic (orbitofrontal cortex, insula, globus pallidus, putamen, hippocampus, and amygdala) and homeostatic (hypothalamus) food motivation and hyperactivation in cognitive control (anterior cingulate and frontopolar cortex) brain regions following oxytocin administration vs placebo. Oxytocin administration reduces the BOLD signal in reward-related food motivation brain regions, providing a potential neurobiological mechanism for the anorexigenic oxytocin effects in humans. Furthermore, our data indicate that oxytocin administration reduces activation in homeostatic and increases activation in cognitive control brain regions critically involved in regulating food intake and resolving affective conflict, respectively. Future studies are required to link these changes in brain activation to oxytocin effects on food intake and weight.

Indexed as

Administration, IntranasalAdultBrainBrain MappingCerebrovascular CirculationCross-Over StudiesDouble-Blind MethodExecutive FunctionFeeding BehaviorHumansMagnetic Resonance ImagingMaleMotivationOverweightOxygenOxytocinOxygenOxytocinPsychotropic Drugs

Identifiers

PMID28930284
PMCPMC5770767
OpenAlexW2755504573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.